氨基樂欣注射液７％

Pays: Taïwan

Langue: chinois

Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Ingrédients actifs:

ISOLEUCINE;;LEUCINE;;LYSINE;;METHIONINE;;PHENYLALANINE;;THREONINE;;TRYPTOPHAN;;VALINE;;TYROSINE;;ALANINE;;ARGININE;;GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL);;PROLINE;;HISTIDINE;;SERINE;;SODIUM HYDROSULFITE (SODIUM DITHIONITE)

Disponible depuis:

美商亞培股份有限公司台灣分公司 台北市中山區民生東路三段49號5、6樓及51號5、6樓 (30961216)

Code ATC:

B05BA01

forme pharmaceutique:

注射劑

Composition:

ALANINE (4020100200) 6.60MG; ARGININE (4020100300) 5.07MG; HISTIDINE (4020100900) 1.54MG; ISOLEUCINE (4020101000) 7.89MG; LEUCINE (4020101200) 15.76MG; LYSINE (4020101300) 2.65MG; METHIONINE (4020101500) 2.06MG; PHENYLALANINE (4020101700) 2.28MG; PROLINE (4020101800) 4.48MG; SERINE (4020101900) 2.21MG; THREONINE (4020102000) 2.72MG; TRYPTOPHAN (4020102100) 0.88MG; TYROSINE (4020102200) 0.33MG; VALINE (4020102300) 7.89MG; GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL) (4020102400) 6.60MG; SODIUM HYDROSULFITE (SODIUM DITHIONITE) (6400001100) (POWDER) 0.60MG

Unités en paquet:

瓶裝

classe:

製　劑

Type d'ordonnance:

限由醫師使用

Fabriqué par:

HOSPIRA INC. NORTH CHICAGO, ILLINOIS, 60064 U.S.A. US

Domaine thérapeutique:

amino acids

indications thérapeutiques:

不能攝取食物之患者之補助治療劑、蛋白質之消化吸收機能及合成利用障礙；嚴重創傷、火傷、骨折時蛋白質之補給、蛋白質攝取減少之營養失調症

Descriptif du produit:

註銷日期: 2013/01/03; 註銷理由: 許可證已逾有效期; 有效日期: 2008/05/25; 英文品名: AMINOSYN-HBC 7% INJECTION

Statut de autorisation:

已註銷

Date de l'autorisation:

1988-05-25